119 related articles for article (PubMed ID: 24366037)
1. Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase α- but not β-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferation.
Waring MJ; Andrews DM; Faulder PF; Flemington V; McKelvie JC; Maman S; Preston M; Raubo P; Robb GR; Roberts K; Rowlinson R; Smith JM; Swarbrick ME; Treinies I; Winter JJ; Wood RJ
Chem Commun (Camb); 2014 May; 50(40):5388-90. PubMed ID: 24366037
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent, selective small molecule inhibitors of α-subtype of type III phosphatidylinositol-4-kinase (PI4KIIIα).
Raubo P; Andrews DM; McKelvie JC; Robb GR; Smith JM; Swarbrick ME; Waring MJ
Bioorg Med Chem Lett; 2015 Aug; 25(16):3189-93. PubMed ID: 26087940
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of hormone-sensitive phosphoinositide pools in the plasma membrane requires phosphatidylinositol 4-kinase IIIalpha.
Balla A; Kim YJ; Varnai P; Szentpetery Z; Knight Z; Shokat KM; Balla T
Mol Biol Cell; 2008 Feb; 19(2):711-21. PubMed ID: 18077555
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 4,5-bisphosphate hydrolysis accompanies T cell receptor-induced apoptosis of murine thymocytes within the thymus.
Conroy LA; Jenkinson EJ; Owen JJ; Michell RH
Eur J Immunol; 1995 Jul; 25(7):1828-35. PubMed ID: 7621860
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 4-kinases, phosphatidylinositol 4-phosphate and cancer.
Waugh MG
Cancer Lett; 2012 Dec; 325(2):125-31. PubMed ID: 22750097
[TBL] [Abstract][Full Text] [Related]
6. Inositol lipid pathways turn turtle.
Hinchliffe K; Irvine R
Nature; 1997 Nov; 390(6656):123-4. PubMed ID: 9367149
[No Abstract] [Full Text] [Related]
7. PIP4K and the role of nuclear phosphoinositides in tumour suppression.
Fiume R; Stijf-Bultsma Y; Shah ZH; Keune WJ; Jones DR; Jude JG; Divecha N
Biochim Biophys Acta; 2015 Jun; 1851(6):898-910. PubMed ID: 25728392
[TBL] [Abstract][Full Text] [Related]
8. Association of T cell antigen CD7 with type II phosphatidylinositol-4 kinase, a key component in pathways of inositol phosphate turnover.
Subrahmanyam G; Rudd CE; Schneider H
Eur J Immunol; 2003 Jan; 33(1):46-52. PubMed ID: 12594831
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR.
Chen SM; Liu JL; Wang X; Liang C; Ding J; Meng LH
Biochem Pharmacol; 2012 May; 83(9):1183-94. PubMed ID: 22305748
[TBL] [Abstract][Full Text] [Related]
10. Transient temporal relationship between 1-oleoyl-2-acetyl-sn-glycerol (OAG)-activated synthesis and hydrolysis of polyphosphoinositides: desensitization of phospholipase C and the inositol lipid kinases upon long-term treatment of ascites cells by exogenous OAG.
Haeffner EW
J Lipid Mediat; 1993 Jul; 7(3):239-52. PubMed ID: 8219004
[TBL] [Abstract][Full Text] [Related]
11. DW09849, a selective phosphatidylinositol 3-kinase (PI3K) inhibitor, prevents PI3K signaling and preferentially inhibits proliferation of cells containing the oncogenic mutation p110α (H1047R).
Liu JL; Gao GR; Zhang X; Cao SF; Guo CL; Wang X; Tong LJ; Ding J; Duan WH; Meng LH
J Pharmacol Exp Ther; 2014 Mar; 348(3):432-41. PubMed ID: 24361696
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by toxin B of inositol phosphate formation induced by G protein-coupled and tyrosine kinase receptors in N1E-115 neuroblastoma cells: involvement of Rho proteins.
Zhang C; Schmidt M; von Eichei-Streiber C; Jakobs KH
Mol Pharmacol; 1996 Oct; 50(4):864-9. PubMed ID: 8863831
[TBL] [Abstract][Full Text] [Related]
13. Identification of inhibitors of inositol 5-phosphatases through multiple screening strategies.
Pirruccello M; Nandez R; Idevall-Hagren O; Alcazar-Roman A; Abriola L; Berwick SA; Lucast L; Morel D; De Camilli P
ACS Chem Biol; 2014 Jun; 9(6):1359-68. PubMed ID: 24742366
[TBL] [Abstract][Full Text] [Related]
14. Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors.
Mortensen DS; Perrin-Ninkovic SM; Harris R; Lee BG; Shevlin G; Hickman M; Khambatta G; Bisonette RR; Fultz KE; Sankar S
Bioorg Med Chem Lett; 2011 Nov; 21(22):6793-9. PubMed ID: 21978683
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent phosphoinositide 3-kinase inhibitors suitable for monitoring of intracellular distribution.
Kim D; Lee H; Jun H; Hong SS; Hong S
Bioorg Med Chem; 2011 Apr; 19(8):2508-16. PubMed ID: 21459582
[TBL] [Abstract][Full Text] [Related]
16. Novel small molecule Raf kinase inhibitors for targeted cancer therapeutics.
Kim DH; Sim T
Arch Pharm Res; 2012 Mar; 35(4):605-15. PubMed ID: 22553052
[TBL] [Abstract][Full Text] [Related]
17. Both phosphatidylinositol 3-kinase and phosphatidylinositol 4-kinase products are increased by antigen receptor signaling in B cells.
Gold MR; Aebersold R
J Immunol; 1994 Jan; 152(1):42-50. PubMed ID: 8254204
[TBL] [Abstract][Full Text] [Related]
18. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
[TBL] [Abstract][Full Text] [Related]
19. Suppression of phospholipase C beta, gamma, and delta families alters cell growth and phosphatidylinositol 4,5-bisphosphate levels.
Nebigil CG
Biochemistry; 1997 Dec; 36(50):15949-58. PubMed ID: 9398329
[TBL] [Abstract][Full Text] [Related]
20. Targeting RSK: an overview of small molecule inhibitors.
Nguyen TL
Anticancer Agents Med Chem; 2008 Oct; 8(7):710-6. PubMed ID: 18855572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
